Psychiatry and Neurology, Neurology · Huntsville, AL
NPI
1013064815
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
185 Chateau Dr SW Ste 301
Huntsville, AL, 35801
Phone (256) 265-2695
Groups this clinician bills Medicare through
Medicare paid, 2024
$406K
31,845 services
Medicare patients, 2024
972
Average age 75
Drug cost, 2024
$6.7M
7,378 prescriptions
Company payments, 2025
$6,693
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Greer was code J0585 (injection, onabotulinumtoxina, 1 unit), 15,050 times for 34 patients. In total David Greer billed 31,845 services in 42 codes, and Medicare paid $406K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 15,050 | 34 | $4.86 | $73K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 12,500 | 29 | $6.17 | $77K |
| 99232 Hospital E&M - Subsequent | Facility | 1,497 | 271 | $59.06 | $88K |
| 99214 Office E&M - Established | Office | 461 | 342 | $80.36 | $37K |
| 99222 Hospital E&M - Initial | Facility | 211 | 204 | $92.92 | $20K |
| 99231 Hospital E&M - Subsequent | Facility | 174 | 139 | $36.63 | $6,374 |
| 99212 Office E&M - Established | Office | 168 | 85 | $40.98 | $6,884 |
| 99239 Hospital Discharge Management | Facility | 164 | 161 | $85.91 | $14K |
| 99213 Office E&M - Established | Office | 149 | 135 | $55.02 | $8,199 |
| 99204 Office E&M - New | Office | 112 | 112 | $114.34 | $13K |
| 95874 Musculoskeletal | Office | 80 | 31 | $51.07 | $4,085 |
| 64615 Musculoskeletal | Office | 63 | 24 | $107.01 | $6,742 |
| 99215 Office E&M - Established | Office | 59 | 56 | $117.34 | $6,923 |
| 64644 Musculoskeletal | Office | 50 | 19 | $123.98 | $6,199 |
| 64612 Musculoskeletal | Office | 31 | 14 | $134.55 | $4,171 |
By year: 2022 $371K for 28,882 services; 2023 $361K for 27,438 services; 2024 $406K for 31,845 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Greer prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 403 prescriptions and refills. In total David Greer wrote 7,378 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 403 | 668 | 91 | $13K |
| Levetiracetam Generic | 388 | 627 | 67 | $15K |
| Gabapentin Generic | 334 | 476 | 88 | $4,124 |
| Lacosamide Generic | 296 | 321 | 28 | $46K |
| Donepezil Hcl Generic | 292 | 578 | 84 | $2,102 |
| Memantine Hcl Generic | 250 | 412 | 55 | $6,532 |
| Clonazepam Generic | 219 | 244 | 29 | $1,872 |
| Primidone Generic | 170 | 299 | 31 | $5,548 |
| Oxcarbazepine Generic | 166 | 211 | 23 | $11K |
| Escitalopram Oxalate Generic | 163 | 262 | 38 | $1,274 |
| Quetiapine Fumarate Generic | 142 | 175 | 35 | $984 |
| Phenobarbital Generic | 125 | 169 | 12 | $3,614 |
| Pregabalin Generic | 119 | 163 | 26 | $5,190 |
| Rivastigmine Generic | 114 | 140 | 21 | $22K |
| Ropinirole Hcl Generic | 114 | 171 | 21 | $1,471 |
Brand drugs: 1,510 claims; generic drugs: 5,742 claims; opioid claims: 132.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Greer $6,693 ($6,693 in general payments such as food, travel and fees) from 37 companies. The largest payer was Abbvie Inc. with $807.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 55 | $807 |
| Pfizer Inc. PFE | 32 | $544 |
| Medtronic, Inc. MDT | 2 | $437 |
| UCB, Inc. UCB.BR | 23 | $415 |
| CSL Behring CSL.AX | 14 | $392 |
| Alexion Pharmaceuticals, Inc. AZN | 8 | $323 |
| Jazz Pharmaceuticals Inc. JAZZ | 10 | $319 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $315 |
| Biogen, Inc. BIIB | 15 | $287 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $267 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.